# OnCo record oncogenic-viruses (pathway). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pathways/oncogenic-viruses/>
  a schema:BioChemEntity ;
  onco:kind "pathway" ;
  schema:identifier "oncogenic-viruses" ;
  schema:name "Oncogenic viruses"@en ;
  schema:description "About one cancer in eight worldwide is caused by a virus. HPV, hepatitis B and C, Epstein-Barr, HTLV-1, KSHV and Merkel cell polyomavirus each hijack the same brakes cancer normally has to mutate, which is why vaccines against HPV and HBV are among the most effective anti-cancer drugs ever made."@en ;
  schema:url <https://onco.cc/pathways/oncogenic-viruses/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Oncovirus> ;
  schema:citation <https://doi.org/10.1016/j.chom.2014.02.011>, <https://publications.iarc.fr/119>, <https://doi.org/10.1038/nrc1452>, <https://doi.org/10.1038/ng.3415> ;
  onco:tag "mechanism", "mechanics-atlas" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/nasopharyngeal/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/merkel-cell-carcinoma/>, <https://onco.cc/cancers/kaposi-sarcoma/>, <https://onco.cc/cancers/anal/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/burkitt-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/hpv-testing/>, <https://onco.cc/technologies/colposcopy-excision/>, <https://onco.cc/technologies/cthpv-dna/>, <https://onco.cc/technologies/hcc-surveillance/>, <https://onco.cc/technologies/tcr-t/> ;
  onco:targets <https://onco.cc/targets/tp53/>, <https://onco.cc/targets/cdk4-6/>, <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/gardasil-9/>, <https://onco.cc/drugs/avelumab/>, <https://onco.cc/drugs/retifanlimab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/cemiplimab/> ;
  onco:pathways <https://onco.cc/pathways/inflammation-nfkb/>, <https://onco.cc/pathways/p53-mdm2-axis/>, <https://onco.cc/pathways/p53-cell-cycle/>, <https://onco.cc/pathways/antigen-presentation-immunoediting/> ;
  onco:terms <https://onco.cc/terms/hpv-p16/>, <https://onco.cc/terms/hbv-hcv/>, <https://onco.cc/terms/plasma-ebv-dna/>, <https://onco.cc/terms/cin-hsil/>, <https://onco.cc/terms/tumor-promoting-inflammation/>, <https://onco.cc/terms/lymphoma-bio-ebv-latency/>, <https://onco.cc/terms/lymphoma-bio-htlv1/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-mesri-cell-host-microbe/> .